Headwall is expanding its Board to leverage global growth opportunities.
The GenASIs advanced cytogenetic and pathology platforms are the foundation of ASI's new offering. ASI provides state of the art diagnostic aids, offering cytogeneticists and pathologists accurate genetic and pathology analysis.